@Tejas pandya
Initially, both companies appear to possess robust fundamentals and exhibit no significant concerns.
Considering your standard practice of applying for 11 BHNI, let's analyze potential scenarios, as per your ask.
To proceed, we must estimate the subscription figure for both IPOs. Let us assume Adhar will be oversubscribed by approximately 5-6 times, while TBO Tek might see a subscription of around 13-15 times.
If you apply 11 BHNI in Adhar and skip TBO Tek, your chance of getting allotment in Adhar is about 6 out of 11, which means you could get 2 allotments. If Adhar gets listed with a 20% higher price, then your profit on 2 applications would be similar to what you might get from 1 allotment in TBO Tek if it lists with a 50% profit. Even you may also get more than 2 allotments in Adhar if you would be lucky on that day.
Hence, opting for full force in Adhar while avoiding TBO Tek seems a prudent strategy, contingent upon the realization of the aforementioned scenarios (real subscription rate + listing estimation). However, there are still uncertainties. Adhar might be oversubscribed more than we expect, or its listing price could be lower than the anticipated 20% premium, or it might even list flat. On the other hand, TBO Tek might not get as much subscription as we think, TBO may also list higher than 50% so If any of these things happen, we could face some setbacks.
Predicting the precise outcome remains elusive. However, given the circumstances, I would advocate for full commitment to Adhar and steering clear of TBO Tek.
Prepare to commit fully to Adhar unless unforeseen developments occur on the final day.
I hope it helps🙌
सर्वे भवन्तु सुखिनः, सर्वे सन्तु निरामयाः
Zerodha (Trading Account)
RHP
IPO Mentor (900+ Posts, 400+ Likes)
IPO Guru (2700+ Posts, 4700+ Likes)
Top Contributor (700+ Posts, 100+ Likes)
